The Antifungal Drugs market size is valued at US$ 17.8 Bn in 2026.
The Antifungal Drugs market is projected to grow at a CAGR of 4% by 2033.
The Antifungal Drugs market growth is driven by rising nosocomial infections, increasing prevalence of infectious diseases, and growing ICU admissions.
The U.S. is the dominating regional market for Antifungal Drugs market.
Pfizer Inc., Novartis AG, Bayer AG, Sanofi S.A., and Merck & Co., Inc. are some leading industry players in the Antifungal Drugs market.